These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9112362)

  • 1. Bilateral reduction mammoplasty in a patient treated with calcium channel blocker and cyclosporine after renal transplant: a case report.
    Pan Y; Grindstaff A; Cassada D; Goldman M; Taylor J
    Transplantation; 1997 Apr; 63(7):1032-3. PubMed ID: 9112362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between cyclosporine A and verapamil, felodipine, and isradipine.
    Yildiz A; Sever MS; Türkmen A; Ecder T; Türk S; Akkaya V; Ark E
    Nephron; 1999 Jan; 81(1):117-8. PubMed ID: 9884436
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early renal graft function in recipients treated with the calcium channel blocker felodipine.
    Nyberg G; Haljamäe U; Herlitz H; Nordén G; Blohmé I
    Scand J Urol Nephrol; 1994 Mar; 28(1):17-20. PubMed ID: 8009187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral mandibular cysts associated with cyclosporine use: a case report.
    De Biase A; Ottolenghi L; Polimeni A; Benvenuto A; Lubrano R; Magliocca FM
    Pediatr Nephrol; 2001 Dec; 16(12):993-5. PubMed ID: 11793087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of oral felodipine on serum cyclosporine concentrations.
    Cohen DJ; Teng SN; Appel GB
    Clin Transplant; 1994 Dec; 8(6):541-5. PubMed ID: 7865916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
    Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment.
    Eggerath J; English H; Leichter JW
    J N Z Soc Periodontol; 2005; (88):7-14. PubMed ID: 16237888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced gingival hyperplasia].
    Nohl F; Ferrari P
    Ther Umsch; 1998 Sep; 55(9):573-5. PubMed ID: 9789475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of marginal parodontium condition in patients after kidney graft treated with calcineurine inhibitors and calcium channel blockers.
    Radwan-Oczko M; Boratynska M; Zietek M
    Bull Group Int Rech Sci Stomatol Odontol; 2004; 46(2-3):46-51. PubMed ID: 16335621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver damage caused by atorvastatin and cyclosporine in patients with renal transplant].
    Ivandić E; Bašić-Jukić N
    Acta Med Croatica; 2014 Apr; 68(2):175-8. PubMed ID: 26012156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.
    Linden GJ; Haworth SE; Maxwell AP; Poulton KV; Dyer PA; Middleton D; Irwin CR; Marley JJ; McNamee P; Short CD; Hull PS; James JA
    J Periodontol; 2001 Jun; 72(6):808-14. PubMed ID: 11453244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report. Use of an argon laser to treat drug-induced gingival overgrowth.
    Mattson JS; Blankenau R; Keene JJ
    J Am Dent Assoc; 1998 Jan; 129(1):78-83. PubMed ID: 9448349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontal management of gingival overgrowth in a renal transplant patient: a case report.
    Giusto TJ
    J N J Dent Assoc; 2005; 76(2):26-9. PubMed ID: 16178180
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
    Kuypers DR; Neumayer HH; Fritsche L; Budde K; Rodicio JL; Vanrenterghem Y;
    Transplantation; 2004 Oct; 78(8):1204-11. PubMed ID: 15502721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast fibroadenomas in renal transplant recipients.
    Alkhunaizi AM; Ismail A; Yousif BM
    Transplant Proc; 2004; 36(6):1839-40. PubMed ID: 15350492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC; Koomans HA
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimus.
    Cota LO; Aquino DR; Franco GC; Cortelli JR; Cortelli SC; Costa FO
    J Clin Periodontol; 2010 Oct; 37(10):894-902. PubMed ID: 20618547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.